Abstract
The diagnostic rate of lung cancer has been improved by the development of the fiberoptic bronchoscope and this instrument has particularly promoted the detection of early stage of central type lung cancer. But therapeutic results have been unsatisfactory, partly because of difficulties in resecting cases with poor pulmonary function. On the other hand, chemotherapy and radiation therapy can have serious side effects. New therapeutic modalities are therefore required for treatment of early stage inoperable lung cancer cases.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Dougherty TJ, Kaufman JH, Goldfarb A, Weishaupt RK, Boyle D, and Mittleman A: Photoradiation Therapy for the Treatment of Malignant Tumors. Cancer Res., 38:2628–2635, 1978.
Dougherty TJ, Lawrence G, Kaufman JH, Boyle D, Weishaupt KR, and Goldfarb A: Photoradiation in the Treatment of Recurrent Breast Carcinoma. J. Natl. Cancer Inst., 62: 231–237, 1979.
Hayata Y, Kato H, Aida M, Konaka C, Ono J, Saito T, Iimura I, Matsushima Y, Yoneyama K, and Nishimiya K: Hematoporphyrin derivative and photoirradiation therapy with argon-dye laser for the treatment of experimentally induced central type lung cancers in dogs. Igakunoayumi (in Japanese) 116:203–205, 1981.
Lipson RL and Baldes J: Photodynamic Properties of a Particular Hematoporphyrin Derivative. Arch. Dermatol. 82:508–516, 1960.
Gomer CJ and Dougherty TJ: Determination of [3H]- and [14C]-Hematoporphyrin Derivative Distribution in Malignant and Normal Tissue. Cancer Res.39:146–151 1979.
Hayata Y, Kato H, Konaka C., Aida M, Iimura I, and Tahara M: Hematoporphyrin derivative and laser photoradiation system in the diagnosis and treatment of lung cancer. Proc. 7th Asia-Pacific Congr. Dis. Chest. 33, 1981.
Hayata Y, Kato H, Konaka C, Ono J, and Takizawa N: Hematoporphyrin derivative and laser photoradiation system in treatment of lung cancer. Chest (in press).
Kato H, Konaka C, Ono J, Matsushima Y, Nishimiya K, Hakoshima A, and Hayata Y: Laser photoradiation with hematoporphyrin derivative in lung cancer. Proc. 4th Congr. Int. Soc. Laser Surgery, Laser-Tokyo ‘81, 14-5–14-8, 1981.
Dougherty TJ, Thoma RE, Boyle DG, and Weishaupt KR: Interstitial photoradiation therapy for primary solid tumors in pet cats and dogs. Cancer Res. 41:401–404, 1981.
Dougherty TJ, Grindy GB, Fiel R, Weishaupt KR, and Boyle DG: Photoradiation therapy. II. Cure of animal tumors with hematoporphyrin and light. J. Natl. Cancer Inst., 55:115–121, 1975.
Weishaupt KR, Gomer CJ, and Dougherty TJ: Identification of singlet oxygen as cytotoxic agent in photoinactiv-ation of murine tumor. Cancer Res. 36:2326–2329, 1976.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Plenum Press, New York
About this chapter
Cite this chapter
Kato, H. et al. (1983). Effectiveness of HPD and Radiation Therapy in Lung Cancer. In: Kessel, D., Dougherty, T.J. (eds) Porphyrin Photosensitization. Advances in Experimental Medicine and Biology, vol 160. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4406-3_4
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4406-3_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4408-7
Online ISBN: 978-1-4684-4406-3
eBook Packages: Springer Book Archive